Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Attune Neurosciences
Attune Neurosciences

Attune Neurosciences

Seed

Attune Neurosciences: Creating non-invasive neurostimulation devices for improved sleep health.

HQ
Menlo Park, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Attune Neurosciences, founded with a mission to enhance human health and performance, is a clinical-stage medical device company specializing in non-invasive neurostimulation products. Their primary focus is on addressing sleep- and wake-related conditions, aiming to support patients, government entities, and industrial applications. By leveraging cutting-edge technology, Attune Neurosciences seeks to provide clinically proven solutions that improve overall well-being.

Notable investors include leading venture capital firms, the National Institutes of Health, the US Special Operations Command (SOCOM), and the US Air Force. These affiliations underscore the company's credibility and potential impact. Attune Neurosciences has achieved significant milestones in developing its innovative medical devices, contributing to advancements in non-invasive neurostimulation therapies. The company's work holds promise for substantial improvements in sleep health and related areas, reflecting its commitment to enhancing quality of life through advanced medical technology.

Attune Neurosciences - Similar Companies

Scion Neurostim logo

Scion Neurostim

scionneurostim.com

neusleep logo

neusleep

neusleep.co

Nia Therapeutics logo

Nia Therapeutics

Invicta Medical logo

Invicta Medical

Epic Neuro logo

Epic Neuro

Auricle logo

Auricle

auricle.com

Neurodyne logo

Neurodyne

StimAire logo

StimAire

stimaire.com

Apex Neuro logo

Apex Neuro

Nexeon Medsystems logo

Nexeon Medsystems

nexeonmed.com

Niche Biomedical logo

Niche Biomedical

Realeve logo

Realeve

NeuroBionics logo

NeuroBionics

neuroFit logo

neuroFit

neurofit.tech

StimScience logo

StimScience

somneesleep.com

Attune Neurosciences - Quick Facts

Who are Attune Neurosciences' competitors?

Companies similar to Attune Neurosciences include Scion Neurostim, neusleep, Nia Therapeutics and Invicta Medical.

When was Attune Neurosciences founded?

Attune Neurosciences was founded in 2019.

Where is Attune Neurosciences' headquarters located?

Attune Neurosciences' headquarters is located in Menlo Park, CA, US.

When was Attune Neurosciences' last funding round?

Attune Neurosciences' most recent funding round was for $3.8M (USD) in April 2021.

How much has Attune Neurosciences raised to-date?

As of Apr 15, 2021, Attune Neurosciences has raised a total of $3.8M (USD).

How many employees does Attune Neurosciences have?

Attune Neurosciences has 14 employees as of Feb 5, 2024.

Attune Neurosciences - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Neurostimulation
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research